Wells Fargo’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$489K Sell
169,636
-133,671
-44% -$340K ﹤0.01% 4646
2026
Q1
$594K Buy
303,307
+139,018
+85% +$326K ﹤0.01% 4055
2025
Q4
$445K Buy
164,289
+119,593
+268% +$393K ﹤0.01% 4576
2025
Q3
$189K Buy
44,696
+6,554
+17% +$28.8K ﹤0.01% 4960
2025
Q2
$190K Sell
38,142
-6,261
-14% -$27.2K ﹤0.01% 4803
2025
Q1
$196K Buy
44,403
+16,897
+61% +$79.3K ﹤0.01% 4720
2024
Q4
$128K Sell
27,506
-81,454
-75% -$448K ﹤0.01% 5060
2024
Q3
$756K Buy
108,960
+71,312
+189% +$560K ﹤0.01% 3727
2024
Q2
$294K Sell
37,648
-120,625
-76% -$893K ﹤0.01% 4254
2024
Q1
$1.12M Buy
158,273
+132,074
+504% +$874K ﹤0.01% 3388
2023
Q4
$176K Sell
26,199
-2,580
-9% -$14.5K ﹤0.01% 4537
2023
Q3
$162K Sell
28,779
-102,119
-78% -$681K ﹤0.01% 4494
2023
Q2
$723K Sell
130,898
-6,281
-5% -$33.8K ﹤0.01% 3682
2023
Q1
$857K Buy
137,179
+31,382
+30% +$175K ﹤0.01% 3481
2022
Q4
$493K Sell
105,797
-28,362
-21% -$140K ﹤0.01% 3650
2022
Q3
$626K Buy
134,159
+58,446
+77% +$368K ﹤0.01% 3556
2022
Q2
$448K Sell
75,713
-30,239
-29% -$337K ﹤0.01% 3805
2022
Q1
$2.05M Buy
105,952
+5,094
+5% +$117K ﹤0.01% 3275
2021
Q4
$3.3M Sell
100,858
-30,377
-23% -$1.22M ﹤0.01% 2994
2021
Q3
$5.38M Sell
131,235
-26,261
-17% -$953K ﹤0.01% 2759
2021
Q2
$5.67M Buy
157,496
+29,457
+23% +$1.09M ﹤0.01% 2755
2021
Q1
$5M Buy
128,039
+61,878
+94% +$2.78M ﹤0.01% 2850
2020
Q4
$2.67M Buy
66,161
+55,620
+528% +$2.56M ﹤0.01% 3284
2020
Q3
$586K Buy
+10,541
New +$558K ﹤0.01% 4230

Other funds holding GDRX

Wells Fargo's GDRX Position: Q2 2026 in Review

Wells Fargo reduced its GoodRx Holdings (GDRX) stake by 44% in Q2 2026, selling an estimated $340K and leaving 169,636 shares worth $489K. The position accounts for ﹤0.01% of the portfolio, ranked #4646.

Wells Fargo first reported a position in GDRX in Q3 2020 and has held it in 24 quarters since. The position peaked at $5.67M in Q2 2021. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Wells Fargo held 169,636 shares of GoodRx Holdings worth $489K as of Q2 2026.
  • Wells Fargo sold 133,671 GoodRx Holdings shares in Q2 2026, an estimated $340K.
  • GoodRx Holdings made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #4646 holding.
  • Wells Fargo first reported a position in GoodRx Holdings in Q3 2020 and has held it in 24 quarters since.
  • Wells Fargo's GoodRx Holdings position peaked at $5.67M in Q2 2021.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.